ThisPlanisformulatedinaccordancewiththe14thFive-YearPlanforNationalEconomicandSocialDevelopmentofthePeople'sRepublicofChinaandtheOutlineoftheVisionGoal2035forthepurposeofensuringdrugsafety,promotinghigh-qualitydevelopmentofdrugs,modernizingthedrugregulatorysystemandregulatorycapacity,andprotectingandpromotingpublichealth.I.Currentsituationandsituation(1)AchievementsmadeDuringthe13thFive-YearPlanperiod,China'sdrugsafetysupervisionsystemandmechanismhavebeengraduallyimproved,thequalityandvarietyofdrugshavebeen...
2022-01-14
InthemorningofJanuary13,2022,ChenKui,deputyDirectorofZhejiangProvincialDrugAdministration,andZhuZhiquan,presidentofZhejiangPharmaceuticalAssociation,ledateamtoinvestigateandinvestigatezhejiangProvincepharmaceuticalMAHtransformationplatform,andhadin-depthdiscussionsandcommunicationwithplatformandrepresentativememberenterpriseHezePharmaceuticalonMAHpracticalexperienceandexistingproblems.LuJianjun,deputysecretaryofpartyWorkingCommitteeanddirectorofmanagementofficeofHangzhouPharmaceuticalPort,attendedthemeeting.TheMAHs...
2022-01-14
Landline: 0574-87882092
Telephone: Manager Li 18961113737
Email address: HR@govinda.net.cn
Company address: 4th floor, Building 1, Phase ii, Jinghua Chuangmeng Space, No. 350 Jinghua Road, High-tech Zone, Ningbo, Zhejiang
Copyright ? Zhejiang Govinda Biomedical Technology Co., LTD. For the record,：浙ICP備2022001272號-1
浙公網(wǎng)安備 33020902000462號